# Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

- Source: CNBC
- Published: 2026-10-20T16:11:02+00:00
- Category: Markets
- Original: https://www.cnbc.com/2026/10/20/novo-cagrisema-women-weight-loss-analysis.html
- Canonical: https://groundlevelnews.com/story/novo-s-next-generation-obesity-drug-shows-25-weight-loss-in-women-in-l-385cbf/

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

_Ground Level News shows a short summary only; the full article and all rights belong to CNBC._